Mumbai
08048034404
+918506873687

🩺 Expert Hepatology & Liver Transplant Update 2025 By Dr. Chetan R. Kalal – Maharashtra’s First DM Hepatologist | India’s Leading Liver & Transplant Specialist



🩺 Expert Hepatology & Liver Transplant Update 2025

By Dr. Chetan R. Kalal – Maharashtra’s First DM Hepatologist | India’s Leading Liver & Transplant Specialist


⚕️ Hepatology Update – The Changing Face of Liver Disease

India is witnessing an unprecedented rise in liver diseases. Fatty liver (MASLD/NASH), alcohol-related cirrhosis, and viral hepatitis are now among the top causes of liver failure. Early detection is key — with tools like FibroScan, MRI-PDFF, and advanced biomarkers allowing diagnosis years before cirrhosis develops.

Dr. Kalal’s View:
"In 2025, hepatology is about prevention and precision. Fatty liver today can become cirrhosis tomorrow if ignored. Regular liver check-ups are as important as sugar or BP testing."


🏥 IPD & Liver Transplant Services in Mumbai

Dr. Kalal provides end-to-end IPD care and advanced liver transplant management across leading hospitals in Mumbai.

IPD Care Includes:

  • Acute liver failure & ICU-level stabilization

  • Cirrhosis complications (ascites, GI bleed, encephalopathy)

  • Bridging therapies: plasma exchange, chelation, infection control

  • Pre- and post-transplant inpatient monitoring

Mumbai Locations Covered:

Patients can be admitted or consult Dr. Kalal in:

  • Andheri | Worli | Lower Parel | South Mumbai

  • Bandra (Pali Hill) | Khar | Lokhandwala | Vile Parle

  • Navi Mumbai | Juhu | Dadar

"A transplant is not just an operation. It is a journey — from IPD stabilization to surgery to lifelong follow-up."


⚖️ Obesity & Liver Health – The Silent Epidemic

Obesity has emerged as the biggest driver of fatty liver, diabetes, and liver cancer in India.

Latest Updates:

  • GLP-1 & GIP agonists (Semaglutide, Tirzepatide): Transforming obesity & fatty liver treatment.

  • Resmetirom (Rezdiffra): First FDA-approved drug for NASH, a global breakthrough.

  • Lifestyle intervention: Even 7–10% weight loss can reverse fatty liver in many patients.

Expert Insight:
"Obesity is not just about weight. It is a metabolic disease that silently damages the liver. With modern medicines and structured clinics, we can finally treat it as a medical condition, not a lifestyle failure."


🌍 Global Virtual Consults & Second Opinions

Dr. Kalal provides virtual consultations and expert second opinions for complex liver and transplant cases across the world.

🌐 Countries & Regions Served:

  • USA, UK, Canada, Europe, Paris, Switzerland

  • UAE, Dubai, Middle East, Africa

  • Australia & New Zealand

Services include:

  • Second opinions on liver transplant decisions

  • Fatty liver and obesity-linked liver disease treatment

  • Cirrhosis and advanced hepatology care

"From Mumbai to Melbourne, Dubai to Paris — patients can access structured, science-backed liver care with just a virtual consultation."


❓ Frequently Asked

Q: Where can I consult Dr. Kalal in Mumbai?
Andheri, Worli, Lower Parel, South Mumbai, Bandra (Pali Hill), Khar, Lokhandwala, Vile Parle, Navi Mumbai.

Q: Does Dr. Kalal offer IPD admissions?
Yes — patients with acute liver failure, cirrhosis, or transplant needs can be admitted under his direct care.

Q: What’s new in obesity treatment for fatty liver?
Modern drugs like GLP-1/GIP agonists and Resmetirom are transforming management alongside lifestyle changes.

Q: Is liver transplant safe in India?
Yes. Mumbai’s outcomes are globally comparable, at a fraction of international costs.

Q: Can I book a virtual second opinion?
Yes. Patients worldwide consult Dr. Kalal online for structured second opinions on complex liver disease.


📢 Conclusion

With expert IPD services, leadership in liver transplant, obesity & fatty liver innovation, and global virtual reach, Dr. Chetan R. Kalal is redefining liver care in India and beyond.

👉 Book your consultation or second opinion at drchetankalal.com



 2025-09-19T05:21:42

Other Pages

View all pages